The move by
into artificial intelligence and its cost-cutting plans are catalysts for growth, according to analysts.
Oppenheimer analyst Jason Helfstein increased his 12-month price target on
(ticker: META) to $235 from $220, which implies a 27% jump from its current share price. Helfstein also maintained his Outperform rating on the stock, and cited multiple near-term catalysts that he thinks will help push shares higher.